1. HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ? 
Giuseppe Bruno, Annalisa Saracino, Luigia Scudeller, Claudia Fabrizio, Raffaele Dell’Acqua, Eugenio Milano, Michele Milella, Nicoletta Ladisa, Laura Monno, Gioacchino Angarano 
International Journal of Infectious Diseases 
Volume 62, Pages (September 2017)
DOI: /j.ijid
Copyright © 2017 The Author(s) Terms and Conditions

2. Figure 1
SVR12 rates according to the use of RBV, diagnosis of cirrhosis, platelet count, albumin level, previous anti-HCV therapy, HIV infection, and HCV genotype 3 vs. other genotypes. Abbreviations: SVR12, sustained virological response (undetectability lasting for 12 consecutive weeks after the cessation of treatment); RBV, ribavirin; GT, genotype.
International Journal of Infectious Diseases  , 64-71DOI: ( /j.ijid )
Copyright © 2017 The Author(s) Terms and Conditions